دورية أكاديمية

A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children.

التفاصيل البيبلوغرافية
العنوان: A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children.
المؤلفون: Pigneur, Bénédicte, Ruemmele, Frank M.
المصدر: Expert Review of Gastroenterology & Hepatology; Nov/Dec2022, Vol. 16 Issue 11/12, p1023-1028, 6p
مصطلحات موضوعية: ULCERATIVE colitis, INFLAMMATORY bowel diseases, CHILD patients, ADALIMUMAB, DRUG monitoring
مستخلص: Anti-tumor necrosis factor (TNF) antibodies play a major role in treating inflammatory bowel disease (IBD), both in adult and pediatric patients. While there is a large number of studies on efficacy and safety of infliximab in treating children and adolescents with ulcerative colitis (UC), data on adalimumab (ADA) are scarce. Here, we review published case reports, cohort and real-time data, as well as the first randomized trial, ENVISION I, using ADA for treating pediatric UC. Available evidence confirms good efficacy in inducing and maintaining remission in children and adolescents with UC, with even higher response rates compared to adult UC. ENVISION I showed that in UC patients responding to ADA induction therapy, almost half of the patients remained in remission after 52 weeks of therapy on high-dosing ADA (weekly administration). As already well experienced with other biologics, dosing schemes are different between pediatric and adult patients, with children often requiring higher dosing. Further data are required to better understand how to optimize ADA therapy. The present and still-growing evidence places subcutaneous (sc.) anti-TNF-medication as alternative first-line therapy also for pediatric UC. This is also reflected by the preference for sc. medication of adolescent patients allowing less frequent and autonomous drug administration. [ABSTRACT FROM AUTHOR]
Copyright of Expert Review of Gastroenterology & Hepatology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17474124
DOI:10.1080/17474124.2022.2149489